HYDROXYPROLINE EXCRETION IS INCREASED IN DIABETES-MELLITUS AND RELATED TO THE PRESENCE OF MICROALBUMINURIA

被引：32

作者：

SELBY, PL

SHEARING, PA

MARSHALL, SM

机构：

[1] Department of Medicine, University of Newcastle upon Tyne, Newcastle Upon Tyne

来源：

DIABETIC MEDICINE | 1995年 / 12卷 / 03期

关键词：

BONE RESORPTION; HYDROXYPROLINE; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHY; MICROALBUMINURIA;

D O I：

10.1111/j.1464-5491.1995.tb00465.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Increased fracture frequency and low bone mass have each been reported in patients with diabetes. To see if these were related to increased bone resorption we have measured the urinary excretion of hydroxyproline in 73 patients with Type 1 (insulin-dependent) diabetes, 67 patients with Type 2 (non-insulin-dependent) diabetes, and 75 control subjects. Hydroxyproline excretion was increased in both types of diabetes: Type 1: 21 (10-36) (median (IQR) mu mol mmol creatinine(-1); Type 2: 25 (13-43) mu mol mmol creatinine-'; control: 10 (6-22) mu mol mmol creatinine(-1) (p < 0.0001 and < 0.0002, respectively). Hydroxyproline excretion was not related to age, duration of diabetes or blood glucose control. Neither was it different in patients with or without retinopathy, neuropathy and macrovascular disease. However it was higher in patients with microalbuminuria at 35 (20-53) (mu mol mmol creatinine(-1) than in those with normal protein excretion (25(13-37) mu mol mmol creatinine(-1) p = 0.03) or those with established proteinuria (18(8-26) pmol mmol creatinine(-1) p = 0.001). We conclude that there is evidence of increased bone resorption in diabetes and that this is related to alterations in renal function.

引用

页码：240 / 243

页数：4

共 20 条

[1] Selby PL., Osteopenia and diabetes, Diabetic Med, 5, pp. 423-428, (1988)
[2] Auwerx J., Dequeker J., Bouillon R., Geusens P., Nijs P., Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus, Diabetes, 37, pp. 8-12, (1988)
[3] Selby PL., Diabetic osteopenia is primarily a disease of trabecular bone characterised by increased resorption, Osteoporosis 1990, pp. 1556-1559, (1990)
[4] Gallacher SJ, Fenner JAK, Fisher BM, Quin JD, Fraser WD, Logue FC, Et al., An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus, Diabetic Med, 10, pp. 129-133, (1993)
[5] de Leeuw I., Mulkens N., Vertommen J., Abs R., A histomorphometric study on the trabecular bone of diabetic subjects, Diabetologia, 12, pp. 385-386, (1976)
[6] Raskin P., Stevenson MR, Barilla DE, Pak CYC., The hypercalciuria of diabetes mellitus
[7] its amelioration with insulin, Clin Endocrinol, 9, pp. 329-335, (1978)
[8] McNair P., Christensen MS, Madsbad S., Christiansen C., Transbol I., Hypoparathyroidism in diabetes mellitus, Acta Endocrinol, 96, pp. 81-86, (1981)
[9] Gertner JM, Tamborlane WV, Horst RL, Sherwin RS, Felig P., Genel M., Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system, J Clin Endocrinol Metab, 50, pp. 862-866, (1980)
[10] Hodgkinson A., Thompson T., Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex, J Clin Pathol, 35, pp. 807-811, (1982)

← 1 2 →